Clinical trial
Telmisartan80/HCTZ25 Versus Telmisartan80/HCTZ12.5 in Hypertension Not…
NCT00239369 · Boehringer Ingelheim, Industry · Completed
Key facts
| NCT number | NCT00239369 |
|---|---|
| Title | Telmisartan80/HCTZ25 Versus Telmisartan80/HCTZ12.5 in Hypertension Not Responding to Telmisartan80/HCTZ12.5 |
| Official title | A Prospective Randomised Study to Compare a Fixed Dose Combination of Telmisartan 80 mg Plus Hydrochlorothiazide 25 mg With a Fixed Dose Combination of Telmisartan 80 mg Plus Hydrochlorothiazide 12.5 mg in Patients With Uncontrolled Hypertension Who Fail to Respond Adequately to Treatment With a… |
| Lead sponsor | Boehringer Ingelheim, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | Fixed dose combination telmisartan 80 mg + HCTZ 25 mg, Fixed dose combination telmisartan 80 mg + HCTZ 12.5 mg |
| Enrollment | 713 |
| Start date | Oct 1, 2005 |
| Primary completion | Aug 1, 2006 |
| Completion | Aug 1, 2006 |
| First posted | Oct 17, 2005 |
| Last update posted | Dec 28, 2017 |
| Countries | Denmark, Finland, France, Germany, Hong Kong, Ireland, Italy, Malaysia, Netherlands, Norway, South Africa, South Korea and 4 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: